Abiomed (ABMD -6.4%) trades down today coming off a 2-day trading halt, touching a 52-week low...

|By:, SA News Editor

Abiomed (ABMD -6.4%) trades down today coming off a 2-day trading halt, touching a 52-week low of $11.80 after the company announced that the FDA Circulatory System Devices Panel voted to retain Class III status for the temporary ventricular support devices within the non-roller type cardiopulmonary bypass blood pumps category - which includes ABMD's Impella - rather than the lower-risk Class II category it had hoped for.